IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effect of Co-enzyme Q10 on cerebral hemodynamics in diabetic patients.

Author: ZAHRAA ALHASSANI, AHMED MH AL-MUDHAFAR, LAITH ALDABBAGH
Abstract: Background: diabetic patients are at greater risk to have cerebrovascular accidents like ischemic stroke, vascular dementia and silent lacunar infarctions. They are also deficient in co-enzyme Q10. Previous studies showed that coenzyme Q10 supplement improves macrovascular complications in diabetic patients.we want to find out the effect of co-enzyme Q10 supplements on cerebral hemodynamics in diabetic patients we randomly choose 48 patients with type 2 DM from diabetic center, where they are randomly grouped into two groups. First group: they have supplement with daily dose of 400mg of co-enzyme Q10 orally for 12 weeks and second group: they have placebo supplement for 12 weeks. All patients have transcranial Doppler before and after treatment. Mean flow velocity of first group before treatment was 49.71±7.43 cm/second , while after treatment it increased to 52.92±6.97 cm/second but this was statistically insignificant (p=0.134). Regarding the second group, MFV before treatment was 50.54±7.91 cm/second, and after treatment was 50.58± 7.1 cm/second. The difference between MFV before and after treatment was negligible and insignificant (p=0.984).Resistive index of first group before treatment was 0.66 ±0.086, while after treatment it decreased to 0.61±0.076. This change after treatment was significant (p=0.030). Regarding the second group, RI before treatment was 0.66± 0.074 and it decreased after treatment to 0.64± 0.072. This change in RI of second group was insignificant (p= 0.628). Therefore, CoQ10 may lower cerebral arterial resistance and improve arterial compliance in diabetic patients.
Keyword: co-enzyme Q10, cerebral hemodynamics, type 2 DM, transcranial Doppler INTRODUCTION Cardiovascular
DOI: https://doi.org/10.31838/ijpr/2019.11.01.038
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477